Similarly, data from another study in people with T2DM with albuminuria on RAS inhibition demonstrated that 6 weeks treatment with dapagliflozin increased serum phosphate, plasma PTH, and FGF-23 (35). Here, FGF23 is linked to type 2 diabetes mellitus.